Department News | April 30, 2025
The Addictions, Drug, and Alcohol Institute (ADAI) is excited to introduce Empathy Lens, a new photo collection providing images related to drug and alcohol use, prevention, treatment, recovery, and harm reduction.
Department News | April 30, 2025
The Addictions, Drug, and Alcohol Institute (ADAI) is excited to introduce Empathy Lens, a new photo collection providing images related to drug and alcohol use, prevention, treatment, recovery, and harm reduction.
Department News | April 30, 2025
A new book published by Oxford University Press, "Redesigning the US Mental Health Care System," brings together an array of experts working to spark lasting change in mental health care systems across the United States.
Department News | April 30, 2025
In October 2024, the Substance Abuse and Mental Health Services Administration (SAMHSA) established the new Center for Mental Health Implementation Support (CMHIS) to provide support for the sustained implementation of effective mental health treatments.
Department News | April 30, 2025
Kate Hoerster, PhD, MPH recently co-presented on a panel at the Society of Behavioral Medicine's Annual Meeting in San Francisco about the MOVED BY LOVE study, which seeks to reduce disparities and ensure Veteran-centered care for Black Veterans.
UW Medicine Newsroom | April 25, 2025
The drugs cannot cure Alzheimer's, says Tom Grabowski, MD, but they appear to help people with mild cognitive impairment and extend the time they're independent and able to manage their daily lives.
UW Medicine Newsroom | April 16, 2025
Recommended reforms focus on providing basic services during incarceration and continuing community care after release. Lydia Chwastiak, MD, MPH and Sarah Walker, PhD, MS are authors on the study.
Kitsap Sun | April 15, 2025
In many ways, people with public insurance like Medicaid have better and more comprehensive access to mental health care than people on very nice private insurance programs, says Jürgen Unützer, MD, MPH.
New York Times Magazine | April 13, 2025
Margaret Sibley, PhD says it is important to remember that many ADHD symptoms are pretty commonplace; at any given moment, an average adult could be experiencing two or three of them – halfway to an official diagnosis.
NBC News | April 13, 2025
According to Tom Grabowski, MD many newer Alzheimer's drugs are at some point funded by NIH in the developmental stages. So if you take away NIH funding, this whole pipeline to therapy will go away.
Right as Rain | April 9, 2025
"The risk-benefit profile of benzos for treating things like anxiety disorder or insomnia is pretty poor," says Andy Saxon, MD.